On September 21, 2017 Roche reported that it will publish its Sales Results for the 3rd Quarter of 2017 prior to the opening of the Swiss Stock Exchange on Thursday October 19th, 2017 (Press release, Hoffmann-La Roche, SEP 21, 2017, View Source [SID1234520584]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

07:00 CEST / 06:00 BST / 01:00 AM EDT / 10:00 PM PDT (evening before)

Release will be e-mailed and posted on the Roche IR website click here
Presentation slides will be posted on the Roche IR website click here

We would like to invite all interested parties to dial in as outlined below:
14:00 – 15:15 CEST / 13:00 – 14:15 BST
08:00 – 09:15 AM EDT / 05:00 – 06:15 AM PDT

Audio webcast and conference call will start with presentations by senior management followed by a Q&A session (live access to the speakers).
Presenters:
Severin Schwan, CEO Roche Group
Daniel O’Day, CEO Roche Pharmaceuticals
Roland Diggelmann, CEO Roche Diagnostics
Alan Hippe, Chief Financial and IT Officer

In order to receive your personal dial-in details and expedite your access to the conference call, please pre-register under this link
If you have not pre-registered please find the dial-in numbers below, we recommend you to dial in to the conference 10-15 min prior to the scheduled start.
+41 (0) 58 310 5000 (Europe and ROW)
+44 (0) 203 059 5862 (UK)
+1 (1) 631 570 5613 (USA Toll Free)
A live audio webcast can be accessed via ir.roche.com .
A replay of the webcast will be available via ir.roche.com .

Best regards,
Karl Mahler
Head of Investor Relations